National Institutes of Health NIDA

National Institutes of Health NIDA

Close: Jul 30, 2026

This is a combined synopsis/solicitation (RFP, solicitation number 75N95026R0007) issued by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to examine the role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders and other health outcomes in people living with HIV. The work will use Veterans Affairs electronic health record data and apply propensity-score matching and multivariable linear regression to estimate changes in outcomes. Responses must be submitted electronically to the contracting officer (Robin Knightly, Robin.Knightly@nih.gov) by the deadline; NAICS 541690 with no set-aside.

National Institutes of Health NIDA

Close: Jul 13, 2026

The National Institutes of Health (NIH), on behalf of the National Institute on Drug Abuse (NIDA) Intramural Research Program in Baltimore, MD, issued a combined synopsis/solicitation (RFQ 75N98026Q00745 / PCA-NIDA-07985) to procure commercial services for preventive maintenance, repair, technical support, and software updates for a Miltenyi Biotec UltraMicroscope Blaze. The notice indicates a non-competitive, firm-fixed-price acquisition (sole-source to Miltenyi Biotec) for a one-year service agreement valued at $36,000 covering the period July 20, 2026–July 19, 2027. Required services include one annual preventive maintenance visit (inspection and replacement of wear parts), technical support during business hours, on-site repair response within two business days, and standard software updates.

National Institutes of Health NIDA

Close: Jun 28, 2026

The NIH Office of the Director (Office of Acquisitions / OLAO) issued a combined synopsis/solicitation as a Notice of Intent to award a non-competitive firm-fixed-price service agreement to Carl Zeiss Microscopy, LLC for maintenance and repair of a Zeiss LSM 880 microscope. The action is being conducted under FAR subpart 12.6 and authorized under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) as a non-competitive procurement. Responses were requested by June 28, 2026; the acquisition is specialized (NAICS 811210, PSC J066) and not set aside.